BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 28389482)

  • 1. What are the risks and benefits of temporarily discontinuing medications to prevent acute kidney injury? A systematic review and meta-analysis.
    Whiting P; Morden A; Tomlinson LA; Caskey F; Blakeman T; Tomson C; Stone T; Richards A; Savović J; Horwood J
    BMJ Open; 2017 Apr; 7(4):e012674. PubMed ID: 28389482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The risks and benefits of patients temporarily discontinuing medications in the event of an intercurrent illness: a systematic review protocol.
    Morden A; Horwood J; Whiting P; Savovic J; Tomlinson L; Blakeman T; Tomson C; Richards A; Stone T; Caskey F
    Syst Rev; 2015 Oct; 4():139. PubMed ID: 26497494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin-Converting Enzyme Inhibitor/Receptor Blocker, Diuretic, or Nonsteroidal Anti-inflammatory Drug Use After Major Surgery and Acute Kidney Injury: A Case-Control Study.
    Roberts DJ; Smith SA; Tan Z; Dixon E; Datta I; Devrome A; Hemmelgarn BR; Tonelli M; Pannu N; James MT
    J Surg Res; 2021 Jul; 263():34-43. PubMed ID: 33631376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug discontinuation before contrast procedures and the effect on acute kidney injury and other clinical outcomes: a systematic review protocol.
    Hiremath S; Kayibanda JF; Chow BJW; Fergusson D; Knoll GA; Shabana W; Lahey B; McBride O; Davis A; Akbari A
    Syst Rev; 2018 Feb; 7(1):34. PubMed ID: 29467030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aldosterone antagonists in addition to renin angiotensin system antagonists for preventing the progression of chronic kidney disease.
    Chung EY; Ruospo M; Natale P; Bolignano D; Navaneethan SD; Palmer SC; Strippoli GF
    Cochrane Database Syst Rev; 2020 Oct; 10(10):CD007004. PubMed ID: 33107592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The association between dual RAAS inhibition and risk of acute kidney injury and hyperkalemia in patients with diabetic kidney disease: a systematic review and meta-analysis.
    Whitlock R; Leon SJ; Manacsa H; Askin N; Rigatto C; Fatoba ST; Farag YMK; Tangri N
    Nephrol Dial Transplant; 2023 Oct; 38(11):2503-2516. PubMed ID: 37309038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined use of nonsteroidal anti-inflammatory drugs with diuretics and/or renin-angiotensin system inhibitors in the community increases the risk of acute kidney injury.
    Dreischulte T; Morales DR; Bell S; Guthrie B
    Kidney Int; 2015 Aug; 88(2):396-403. PubMed ID: 25874600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prescription of renin-angiotensin system blockers and risk of acute kidney injury: a population-based cohort study.
    Mansfield KE; Nitsch D; Smeeth L; Bhaskaran K; Tomlinson LA
    BMJ Open; 2016 Dec; 6(12):e012690. PubMed ID: 28003286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of withdrawing vs continuing renin-angiotensin blockers on incidence of acute kidney injury in patients with renal insufficiency undergoing cardiac catheterization: Results from the Angiotensin Converting Enzyme Inhibitor/Angiotensin Receptor Blocker and Contrast Induced Nephropathy in Patients Receiving Cardiac Catheterization (CAPTAIN) trial.
    Bainey KR; Rahim S; Etherington K; Rokoss ML; Natarajan MK; Velianou JL; Brons S; Mehta SR;
    Am Heart J; 2015 Jul; 170(1):110-6. PubMed ID: 26093871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers and Acute Kidney Disease after an Episode of AKI: A Multicenter Prospective Cohort Study.
    Hines A; Li X; Ortiz-Soriano V; Saleh S; Litteral J; Ruiz-Conejo M; Wald R; Silver SA; Neyra JA
    Am J Nephrol; 2020; 51(4):266-275. PubMed ID: 32088714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renin-Angiotensin System Blockade after Acute Kidney Injury (AKI) and Risk of Recurrent AKI.
    Hsu CY; Liu KD; Yang J; Glidden DV; Tan TC; Pravoverov L; Zheng S; Go AS
    Clin J Am Soc Nephrol; 2020 Jan; 15(1):26-34. PubMed ID: 31843974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of triple whammy acute kidney injury.
    Prieto-García L; Pericacho M; Sancho-Martínez SM; Sánchez Á; Martínez-Salgado C; López-Novoa JM; López-Hernández FJ
    Pharmacol Ther; 2016 Nov; 167():132-145. PubMed ID: 27490717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Concomitant Use of Diuretics, Non-Steroidal Anti-Inflammatory Drugs, and Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers (Triple Whammy), Extreme Heat, and In-Hospital Acute Kidney Injury in Older Medical Patients.
    Mangoni AA; Kholmurodova F; Mayner L; Hakendorf P; Woodman RJ
    Adv Ther; 2017 Nov; 34(11):2534-2541. PubMed ID: 29116624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute kidney injury secondary to a combination of renin-angiotensin system inhibitors, diuretics and NSAIDS: "The Triple Whammy".
    Camin RM; Cols M; Chevarria JL; Osuna RG; Carreras M; Lisbona JM; Coderch J
    Nefrologia; 2015; 35(2):197-206. PubMed ID: 26300514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study of Acute Kidney Injury on 309 Hypertensive Inpatients with ACEI/ARB - Diuretic Treatment.
    Chen Q; Zhu S; Liao J; He W
    J Natl Med Assoc; 2018 Jun; 110(3):287-296. PubMed ID: 29778133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stopping renin-angiotensin system blockers after acute kidney injury and risk of adverse outcomes: parallel population-based cohort studies in English and Swedish routine care.
    Bidulka P; Fu EL; Leyrat C; Kalogirou F; McAllister KSL; Kingdon EJ; Mansfield KE; Iwagami M; Smeeth L; Clase CM; Bhaskaran K; van Diepen M; Carrero JJ; Nitsch D; Tomlinson LA
    BMC Med; 2020 Jul; 18(1):195. PubMed ID: 32723383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative angiotensin-converting enzyme inhibitors and angiotensin receptor blocker use and acute kidney injury in patients undergoing cardiac surgery.
    Coca SG; Garg AX; Swaminathan M; Garwood S; Hong K; Thiessen-Philbrook H; Passik C; Koyner JL; Parikh CR;
    Nephrol Dial Transplant; 2013 Nov; 28(11):2787-99. PubMed ID: 24081864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Chronic Effects on Kidney Function by "Triple Whammy" (Combination of Renin and Angiotensin Type Inhibitor, Diuretic Drug and Nonsteroidal Anti-inflammatory Drug)].
    Kunitsu Y; Isono T; Hira D; Terada T
    Yakugaku Zasshi; 2019; 139(11):1457-1462. PubMed ID: 31685742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of acute kidney injury by initiation of non-steroidal anti-inflammatory drugs in hospitalised patients treated with diuretics and renin-angiotensin-aldosterone system inhibitors.
    Bories M; Bacle A; Gilardi H; Le Corre P
    Eur J Hosp Pharm; 2022 Nov; 29(6):359-361. PubMed ID: 33478983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time until onset of acute kidney injury by combination therapy with "Triple Whammy" drugs obtained from Japanese Adverse Drug Event Report database.
    Kunitsu Y; Hira D; Morikochi A; Ueda T; Isono T; Morita SY; Terada T
    PLoS One; 2022; 17(2):e0263682. PubMed ID: 35139129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.